Swedish Orphan Biovitrum AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 22,123 million compared to SEK 18,790 million a year ago. Net income was SEK 2,409 million compared to SEK 2,638 million a year ago.

Basic earnings per share from continuing operations was SEK 7.47. Diluted earnings per share from continuing operations was SEK 7.39.